Alembic Pharmaceuticals receives final USFDA approval for Dapsone Gel, 5%for topical treatment of acne vulgaris
Alembic Pharmaceuticals Limited has secured final regulatory clearance from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for...
Viatris’ VR-205 Shows Strong Phase 3 Results in Japanese IgA Nephropathy Patients
Viatris Inc. (Nasdaq: VTRS) - reported encouraging top-line data from a Phase 3 trial of VR-205, a targeted-release budesonide therapy marketed elsewhere as Tarpeyo and Kinpeygo, in Japanese adults living...
Lupin Secures U.S. FDA Tentative Approval for Enzalutamide Tablets
Lupin Limited (Lupin) the Mumbai, India based global pharma major earlier this week had announced that the company has received tentative approval from the...
Mayo Clinic Finds Common Surgical Drug Could Reduce Risk of Liver Failure
Researchers at Mayo Clinic and Michigan State University have uncovered a potentially life-saving application for tranexamic acid, a widely used clot-preserving medication, in the context of...
New Hope for Thyroid Eye Disease Treatment as FDA Approves Lumvoa
Waltham-based Viridian Therapeutics (Nasdaq: VRDN) has secured U.S. Food and Drug Administration clearance for Lumvoa™ (veligrotug-vvze), marking the company's debut as a commercial-stage biotech and...
FDA Approves AbbVie’s SKYRIZI®️ for Pediatric Patients with Psoriatic Disease
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for children aged six and older living with moderate-to-severe plaque...
